epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Siliq

brodalumab

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Appropriate Use

restricted distribution program (Siliq REMS) due to risk of suicidality; prescribers, pharmacies must be certified and patients must sign a patient-prescriber agreement form; 1-855-511-6135 or www.siliqems.com for more information

Suicidality

incr. risk of suicidality in patients with history of depression and/or suicidal ideation; weigh risk vs. benefit; advise patients and caregivers to seek medical attention for suicidality, new onset or worsening depression, anxiety, or other mood changes

Adult Dosing .

Dosage forms:  INJ (pre-filled syringe): 210 mg per 1.5 mL

Restricted Distribution in US

[1-855-511-6135 or www.siliqrems.com for more information]

psoriasis, moderate-severe plaque

[210 mg SC q2wk]
Start: 210 mg SC x1 on wk 0, 1, 2, then q2wk; Info: consider D/C if inadequate response after 12-16 wk

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@27ab6fef
  • hypersensitivity to drug or ingredient
  • Crohn disease
  • Crohn disease history
  • infection, active
  • TB infection, active
  • caution: infection, chronic
  • caution: infection, recurrent
  • caution: infection risk
  • caution: TB infection, latent
  • caution: TB infection risk
  • caution: depression
  • caution: depression history
  • caution: suicidality history

Drug Interactions .

Overview

brodalumab

IL-17 antagonist

Interaction Characteristics:
  • immunomodulatory effects
Other Info
  • caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Contraindicated

  • adenovirus vaccine, live
  • Siliq (brodalumab)
    +
    adenovirus vaccine, live
    1 interaction

    Contraindicated

    brodalumab + adenovirus vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • BCG live intravesical
  • Siliq (brodalumab)
    +
    BCG live intravesical
    1 interaction

    Contraindicated

    brodalumab + BCG live intravesical

    contraindicated: combo may incr. risk of disseminated BCG infection; may decr. immune response (immunosuppressive effects)

  • chikungunya vaccine, live
  • Siliq (brodalumab)
    +
    chikungunya vaccine, live
    1 interaction

    Contraindicated

    brodalumab + chikungunya vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cholera vaccine, live
  • Siliq (brodalumab)
    +
    cholera vaccine, live
    1 interaction

    Contraindicated

    brodalumab + cholera vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dengue vaccine, live
  • Siliq (brodalumab)
    +
    dengue vaccine, live
    1 interaction

    Contraindicated

    brodalumab + dengue vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • influenza nasal vaccine, live
  • Siliq (brodalumab)
    +
    influenza nasal vaccine, live
    1 interaction

    Contraindicated

    brodalumab + influenza nasal vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • measles/mumps/rubella vaccine, live
  • Siliq (brodalumab)
    +
    measles/ mumps/ rubella vaccine, live
    1 interaction

    Contraindicated

    brodalumab + measles/ mumps/ rubella vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rotavirus vaccine, live
  • Siliq (brodalumab)
    +
    rotavirus vaccine, live
    1 interaction

    Contraindicated

    brodalumab + rotavirus vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • smallpox vaccine, live
  • Siliq (brodalumab)
    +
    smallpox vaccine, live
    1 interaction

    Contraindicated

    brodalumab + smallpox vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • talimogene laherparepvec
  • Siliq (brodalumab)
    +
    talimogene laherparepvec
    1 interaction

    Contraindicated

    brodalumab + talimogene laherparepvec

    contraindicated: combo may incr. risk of disseminated herpetic infection; may decr. immune response (immunosuppressive effects)

  • typhoid vaccine, live
  • Siliq (brodalumab)
    +
    typhoid vaccine, live
    1 interaction

    Contraindicated

    brodalumab + typhoid vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • varicella vaccine, live
  • Siliq (brodalumab)
    +
    varicella vaccine, live
    1 interaction

    Contraindicated

    brodalumab + varicella vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • yellow fever vaccine, live
  • Siliq (brodalumab)
    +
    yellow fever vaccine, live
    1 interaction

    Contraindicated

    brodalumab + yellow fever vaccine, live

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

Avoid/Use Alternative

  • abrocitinib
  • Siliq (brodalumab)
    +
    abrocitinib
    1 interaction

    Avoid/Use Alternative

    brodalumab + abrocitinib

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • adalimumab
  • Siliq (brodalumab)
    +
    adalimumab
    1 interaction

    Avoid/Use Alternative

    brodalumab + adalimumab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • anifrolumab
  • Siliq (brodalumab)
    +
    anifrolumab
    1 interaction

    Avoid/Use Alternative

    brodalumab + anifrolumab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • cladribine oral
  • Siliq (brodalumab)
    +
    cladribine oral
    1 interaction

    Avoid/Use Alternative

    brodalumab + cladribine oral

    use alternative: combo may incr. risk of serious infection (additive effects)

  • deuruxolitinib
  • Siliq (brodalumab)
    +
    deuruxolitinib
    1 interaction

    Avoid/Use Alternative

    brodalumab + deuruxolitinib

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • etrasimod
  • Siliq (brodalumab)
    +
    etrasimod
    1 interaction

    Avoid/Use Alternative

    brodalumab + etrasimod

    avoid combo during and x5wk after etrasimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • infliximab
  • Siliq (brodalumab)
    +
    infliximab
    1 interaction

    Avoid/Use Alternative

    brodalumab + infliximab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • natalizumab
  • Siliq (brodalumab)
    +
    natalizumab
    1 interaction

    Avoid/Use Alternative

    brodalumab + natalizumab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • pimecrolimus topical
  • Siliq (brodalumab)
    +
    pimecrolimus topical
    1 interaction

    Avoid/Use Alternative

    brodalumab + pimecrolimus topical

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • rabies vaccine
  • Siliq (brodalumab)
    +
    rabies vaccine
    1 interaction

    Avoid/Use Alternative

    brodalumab + rabies vaccine

    if possible, avoid immunosuppressive tx or vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ritlecitinib
  • Siliq (brodalumab)
    +
    ritlecitinib
    1 interaction

    Avoid/Use Alternative

    brodalumab + ritlecitinib

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • ruxolitinib topical
  • Siliq (brodalumab)
    +
    ruxolitinib topical
    1 interaction

    Avoid/Use Alternative

    brodalumab + ruxolitinib topical

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • upadacitinib
  • Siliq (brodalumab)
    +
    upadacitinib
    1 interaction

    Avoid/Use Alternative

    brodalumab + upadacitinib

    avoid combo: combo may incr. risk of serious infection (additive effects)

Monitor/Modify Tx

  • anthrax vaccine
  • Siliq (brodalumab)
    +
    anthrax vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + anthrax vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • carfilzomib
  • Siliq (brodalumab)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    brodalumab + carfilzomib

    consider antiviral prophylaxis: combo may incr. risk of serious infection (additive effects)

  • chikungunya vaccine
  • Siliq (brodalumab)
    +
    chikungunya vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + chikungunya vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • COVID-19 vaccine
  • Siliq (brodalumab)
    +
    COVID-19 vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + COVID-19 vaccine

    if possible, vaccinate at least 2wk before or 3mo after brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • diphtheria/tetanus vaccine
  • Siliq (brodalumab)
    +
    diphtheria/ tetanus vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + diphtheria/ tetanus vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • diphtheria/tetanus/pertussis vaccine
  • Siliq (brodalumab)
    +
    diphtheria/ tetanus/ pertussis vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + diphtheria/ tetanus/ pertussis vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ebola vaccine, live
  • Siliq (brodalumab)
    +
    ebola vaccine, live
    1 interaction

    Monitor/Modify Tx

    brodalumab + ebola vaccine, live

    consider vaccinating at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response; may incr. risk of mild vesicular stomatitis virus infection (immunosuppressive effects, recombinant vaccine with vesicular stomatitis virus vector)

  • everolimus
  • Siliq (brodalumab)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    brodalumab + everolimus

    admin. PCP prophylaxis: combo may incr. risk of serious infection (additive effects)

  • Haemophilus b vaccine
  • Siliq (brodalumab)
    +
    Haemophilus b vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + Haemophilus b vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hepatitis A vaccine
  • Siliq (brodalumab)
    +
    hepatitis A vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + hepatitis A vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hepatitis B vaccine
  • Siliq (brodalumab)
    +
    hepatitis B vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + hepatitis B vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • human papillomavirus vaccine
  • Siliq (brodalumab)
    +
    human papillomavirus vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + human papillomavirus vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • influenza H5N1 vaccine
  • Siliq (brodalumab)
    +
    influenza H5N1 vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + influenza H5N1 vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • influenza vaccine
  • Siliq (brodalumab)
    +
    influenza vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + influenza vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider vaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • Japanese encephalitis vaccine
  • Siliq (brodalumab)
    +
    Japanese encephalitis vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + Japanese encephalitis vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • meningococcal vaccine
  • Siliq (brodalumab)
    +
    meningococcal vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + meningococcal vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • mitomycin
  • Siliq (brodalumab)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    brodalumab + mitomycin

    caution advised; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of serious infection (additive effects)

  • pneumococcal vaccine
  • Siliq (brodalumab)
    +
    pneumococcal vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + pneumococcal vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • poliovirus vaccine
  • Siliq (brodalumab)
    +
    poliovirus vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + poliovirus vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • respiratory syncytial virus vaccine
  • Siliq (brodalumab)
    +
    respiratory syncytial virus vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + respiratory syncytial virus vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • sipuleucel-T
  • Siliq (brodalumab)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    brodalumab + sipuleucel-T

    consider decr. brodalumab dose or D/C during leukapheresis and sipuleucel-T admin.: combo may decr. efficacy of sipuleucel-T; may incr. risk of adverse effects (antagonistic effects)

  • smallpox/mpox vaccine, live
  • Siliq (brodalumab)
    +
    smallpox/ mpox vaccine, live
    1 interaction

    Monitor/Modify Tx

    brodalumab + smallpox/ mpox vaccine, live

    consider vaccinating at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response (immunosuppressive effects)

  • tick-borne encephalitis vaccine
  • Siliq (brodalumab)
    +
    tick-borne encephalitis vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + tick-borne encephalitis vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

  • typhoid vaccine
  • Siliq (brodalumab)
    +
    typhoid vaccine
    1 interaction

    Monitor/Modify Tx

    brodalumab + typhoid vaccine

    if possible, vaccinate at least 2wk before starting brodalumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

Caution Advised

  • abatacept
  • Siliq (brodalumab)
    +
    abatacept
    1 interaction

    Caution Advised

    brodalumab + abatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • abemaciclib
  • Siliq (brodalumab)
    +
    abemaciclib
    1 interaction

    Caution Advised

    brodalumab + abemaciclib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • acalabrutinib
  • Siliq (brodalumab)
    +
    acalabrutinib
    1 interaction

    Caution Advised

    brodalumab + acalabrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • afamitresgene autoleucel
  • Siliq (brodalumab)
    +
    afamitresgene autoleucel
    1 interaction

    Caution Advised

    brodalumab + afamitresgene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • aldesleukin
  • Siliq (brodalumab)
    +
    aldesleukin
    1 interaction

    Caution Advised

    brodalumab + aldesleukin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • alemtuzumab
  • Siliq (brodalumab)
    +
    alemtuzumab
    1 interaction

    Caution Advised

    brodalumab + alemtuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anakinra
  • Siliq (brodalumab)
    +
    anakinra
    1 interaction

    Caution Advised

    brodalumab + anakinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anti-thymocyte globulin
  • Siliq (brodalumab)
    +
    anti-thymocyte globulin
    1 interaction

    Caution Advised

    brodalumab + anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • atidarsagene autotemcel
  • Siliq (brodalumab)
    +
    atidarsagene autotemcel
    1 interaction

    Caution Advised

    brodalumab + atidarsagene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • avacopan
  • Siliq (brodalumab)
    +
    avacopan
    1 interaction

    Caution Advised

    brodalumab + avacopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • axicabtagene ciloleucel
  • Siliq (brodalumab)
    +
    axicabtagene ciloleucel
    1 interaction

    Caution Advised

    brodalumab + axicabtagene ciloleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azacitidine
  • Siliq (brodalumab)
    +
    azacitidine
    1 interaction

    Caution Advised

    brodalumab + azacitidine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azathioprine
  • Siliq (brodalumab)
    +
    azathioprine
    1 interaction

    Caution Advised

    brodalumab + azathioprine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • baricitinib
  • Siliq (brodalumab)
    +
    baricitinib
    1 interaction

    Caution Advised

    brodalumab + baricitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • basiliximab
  • Siliq (brodalumab)
    +
    basiliximab
    1 interaction

    Caution Advised

    brodalumab + basiliximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • beclomethasone inhaled
  • Siliq (brodalumab)
    +
    beclomethasone inhaled
    1 interaction

    Caution Advised

    brodalumab + beclomethasone inhaled

    caution advised: combo may incr. risk of serious infection (additive effects)

  • beclomethasone nasal
  • Siliq (brodalumab)
    +
    beclomethasone nasal
    1 interaction

    Caution Advised

    brodalumab + beclomethasone nasal

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belatacept
  • Siliq (brodalumab)
    +
    belatacept
    1 interaction

    Caution Advised

    brodalumab + belatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belimumab
  • Siliq (brodalumab)
    +
    belimumab
    1 interaction

    Caution Advised

    brodalumab + belimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belinostat
  • Siliq (brodalumab)
    +
    belinostat
    1 interaction

    Caution Advised

    brodalumab + belinostat

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bendamustine
  • Siliq (brodalumab)
    +
    bendamustine
    1 interaction

    Caution Advised

    brodalumab + bendamustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • betamethasone
  • Siliq (brodalumab)
    +
    betamethasone
    1 interaction

    Caution Advised

    brodalumab + betamethasone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bimekizumab
  • Siliq (brodalumab)
    +
    bimekizumab
    1 interaction

    Caution Advised

    brodalumab + bimekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • blinatumomab
  • Siliq (brodalumab)
    +
    blinatumomab
    1 interaction

    Caution Advised

    brodalumab + blinatumomab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bortezomib
  • Siliq (brodalumab)
    +
    bortezomib
    1 interaction

    Caution Advised

    brodalumab + bortezomib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • brentuximab vedotin
  • Siliq (brodalumab)
    +
    brentuximab vedotin
    1 interaction

    Caution Advised

    brodalumab + brentuximab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • brexucabtagene autoleucel
  • Siliq (brodalumab)
    +
    brexucabtagene autoleucel
    1 interaction

    Caution Advised

    brodalumab + brexucabtagene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • budesonide
  • Siliq (brodalumab)
    +
    budesonide
    1 interaction

    Caution Advised

    brodalumab + budesonide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • budesonide inhaled
  • Siliq (brodalumab)
    +
    budesonide inhaled
    1 interaction

    Caution Advised

    brodalumab + budesonide inhaled

    caution advised: combo may incr. risk of serious infection (additive effects)

  • budesonide nasal
  • Siliq (brodalumab)
    +
    budesonide nasal
    1 interaction

    Caution Advised

    brodalumab + budesonide nasal

    caution advised: combo may incr. risk of serious infection (additive effects)

  • budesonide rectal
  • Siliq (brodalumab)
    +
    budesonide rectal
    1 interaction

    Caution Advised

    brodalumab + budesonide rectal

    caution advised: combo may incr. risk of serious infection (additive effects)

  • busulfan
  • Siliq (brodalumab)
    +
    busulfan
    1 interaction

    Caution Advised

    brodalumab + busulfan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cabazitaxel
  • Siliq (brodalumab)
    +
    cabazitaxel
    1 interaction

    Caution Advised

    brodalumab + cabazitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • canakinumab
  • Siliq (brodalumab)
    +
    canakinumab
    1 interaction

    Caution Advised

    brodalumab + canakinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carboplatin
  • Siliq (brodalumab)
    +
    carboplatin
    1 interaction

    Caution Advised

    brodalumab + carboplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carmustine
  • Siliq (brodalumab)
    +
    carmustine
    1 interaction

    Caution Advised

    brodalumab + carmustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • certolizumab pegol
  • Siliq (brodalumab)
    +
    certolizumab pegol
    1 interaction

    Caution Advised

    brodalumab + certolizumab pegol

    caution advised: combo may incr. risk of serious infection (additive effects)

  • chlorambucil
  • Siliq (brodalumab)
    +
    chlorambucil
    1 interaction

    Caution Advised

    brodalumab + chlorambucil

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ciltacabtagene autoleucel
  • Siliq (brodalumab)
    +
    ciltacabtagene autoleucel
    1 interaction

    Caution Advised

    brodalumab + ciltacabtagene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cisplatin
  • Siliq (brodalumab)
    +
    cisplatin
    1 interaction

    Caution Advised

    brodalumab + cisplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cladribine injection
  • Siliq (brodalumab)
    +
    cladribine injection
    1 interaction

    Caution Advised

    brodalumab + cladribine injection

    caution advised: combo may incr. risk of serious infection (additive effects)

  • clobetasol ophthalmic
  • Siliq (brodalumab)
    +
    clobetasol ophthalmic
    1 interaction

    Caution Advised

    brodalumab + clobetasol ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • clofarabine
  • Siliq (brodalumab)
    +
    clofarabine
    1 interaction

    Caution Advised

    brodalumab + clofarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • coccidioides immitis skin test antigen
  • Siliq (brodalumab)
    +
    coccidioides immitis skin test antigen
    1 interaction

    Caution Advised

    brodalumab + coccidioides immitis skin test antigen

    caution advised: combo may interfere with test results (antagonistic effects)

  • copanlisib
  • Siliq (brodalumab)
    +
    copanlisib
    1 interaction

    Caution Advised

    brodalumab + copanlisib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • corticotropin
  • Siliq (brodalumab)
    +
    corticotropin
    1 interaction

    Caution Advised

    brodalumab + corticotropin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cortisone
  • Siliq (brodalumab)
    +
    cortisone
    1 interaction

    Caution Advised

    brodalumab + cortisone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • crovalimab
  • Siliq (brodalumab)
    +
    crovalimab
    1 interaction

    Caution Advised

    brodalumab + crovalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cyclophosphamide
  • Siliq (brodalumab)
    +
    cyclophosphamide
    1 interaction

    Caution Advised

    brodalumab + cyclophosphamide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cyclosporine
  • Siliq (brodalumab)
    +
    cyclosporine
    1 interaction

    Caution Advised

    brodalumab + cyclosporine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cytarabine
  • Siliq (brodalumab)
    +
    cytarabine
    1 interaction

    Caution Advised

    brodalumab + cytarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dactinomycin
  • Siliq (brodalumab)
    +
    dactinomycin
    1 interaction

    Caution Advised

    brodalumab + dactinomycin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • danicopan
  • Siliq (brodalumab)
    +
    danicopan
    1 interaction

    Caution Advised

    brodalumab + danicopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • daratumumab
  • Siliq (brodalumab)
    +
    daratumumab
    1 interaction

    Caution Advised

    brodalumab + daratumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • daunorubicin
  • Siliq (brodalumab)
    +
    daunorubicin
    1 interaction

    Caution Advised

    brodalumab + daunorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • decitabine
  • Siliq (brodalumab)
    +
    decitabine
    1 interaction

    Caution Advised

    brodalumab + decitabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deflazacort
  • Siliq (brodalumab)
    +
    deflazacort
    1 interaction

    Caution Advised

    brodalumab + deflazacort

    caution advised: combo may incr. risk of serious infection (additive effects)

  • delgocitinib topical
  • Siliq (brodalumab)
    +
    delgocitinib topical
    1 interaction

    Caution Advised

    brodalumab + delgocitinib topical

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deucravacitinib
  • Siliq (brodalumab)
    +
    deucravacitinib
    1 interaction

    Caution Advised

    brodalumab + deucravacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dexamethasone
  • Siliq (brodalumab)
    +
    dexamethasone
    1 interaction

    Caution Advised

    brodalumab + dexamethasone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dexamethasone ophthalmic
  • Siliq (brodalumab)
    +
    dexamethasone ophthalmic
    1 interaction

    Caution Advised

    brodalumab + dexamethasone ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • difluprednate ophthalmic
  • Siliq (brodalumab)
    +
    difluprednate ophthalmic
    1 interaction

    Caution Advised

    brodalumab + difluprednate ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dimethyl fumarate
  • Siliq (brodalumab)
    +
    dimethyl fumarate
    1 interaction

    Caution Advised

    brodalumab + dimethyl fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dinutuximab
  • Siliq (brodalumab)
    +
    dinutuximab
    1 interaction

    Caution Advised

    brodalumab + dinutuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • diroximel fumarate
  • Siliq (brodalumab)
    +
    diroximel fumarate
    1 interaction

    Caution Advised

    brodalumab + diroximel fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • docetaxel
  • Siliq (brodalumab)
    +
    docetaxel
    1 interaction

    Caution Advised

    brodalumab + docetaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • doxorubicin
  • Siliq (brodalumab)
    +
    doxorubicin
    1 interaction

    Caution Advised

    brodalumab + doxorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dupilumab
  • Siliq (brodalumab)
    +
    dupilumab
    1 interaction

    Caution Advised

    brodalumab + dupilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • duvelisib
  • Siliq (brodalumab)
    +
    duvelisib
    1 interaction

    Caution Advised

    brodalumab + duvelisib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • eculizumab
  • Siliq (brodalumab)
    +
    eculizumab
    1 interaction

    Caution Advised

    brodalumab + eculizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • efgartigimod alfa
  • Siliq (brodalumab)
    +
    efgartigimod alfa
    1 interaction

    Caution Advised

    brodalumab + efgartigimod alfa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elivaldogene autotemcel
  • Siliq (brodalumab)
    +
    elivaldogene autotemcel
    1 interaction

    Caution Advised

    brodalumab + elivaldogene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elotuzumab
  • Siliq (brodalumab)
    +
    elotuzumab
    1 interaction

    Caution Advised

    brodalumab + elotuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elranatamab
  • Siliq (brodalumab)
    +
    elranatamab
    1 interaction

    Caution Advised

    brodalumab + elranatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • emapalumab
  • Siliq (brodalumab)
    +
    emapalumab
    1 interaction

    Caution Advised

    brodalumab + emapalumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • epcoritamab
  • Siliq (brodalumab)
    +
    epcoritamab
    1 interaction

    Caution Advised

    brodalumab + epcoritamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • epirubicin
  • Siliq (brodalumab)
    +
    epirubicin
    1 interaction

    Caution Advised

    brodalumab + epirubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • eribulin
  • Siliq (brodalumab)
    +
    eribulin
    1 interaction

    Caution Advised

    brodalumab + eribulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etanercept
  • Siliq (brodalumab)
    +
    etanercept
    1 interaction

    Caution Advised

    brodalumab + etanercept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etoposide
  • Siliq (brodalumab)
    +
    etoposide
    1 interaction

    Caution Advised

    brodalumab + etoposide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etuvetidigene autotemcel
  • Siliq (brodalumab)
    +
    etuvetidigene autotemcel
    1 interaction

    Caution Advised

    brodalumab + etuvetidigene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fingolimod
  • Siliq (brodalumab)
    +
    fingolimod
    1 interaction

    Caution Advised

    brodalumab + fingolimod

    caution advised during and x2mo after fingolimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • floxuridine
  • Siliq (brodalumab)
    +
    floxuridine
    1 interaction

    Caution Advised

    brodalumab + floxuridine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fludarabine
  • Siliq (brodalumab)
    +
    fludarabine
    1 interaction

    Caution Advised

    brodalumab + fludarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fludrocortisone
  • Siliq (brodalumab)
    +
    fludrocortisone
    1 interaction

    Caution Advised

    brodalumab + fludrocortisone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • flunisolide nasal
  • Siliq (brodalumab)
    +
    flunisolide nasal
    1 interaction

    Caution Advised

    brodalumab + flunisolide nasal

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fluocinolone intravitreal
  • Siliq (brodalumab)
    +
    fluocinolone intravitreal
    1 interaction

    Caution Advised

    brodalumab + fluocinolone intravitreal

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fluorometholone ophthalmic
  • Siliq (brodalumab)
    +
    fluorometholone ophthalmic
    1 interaction

    Caution Advised

    brodalumab + fluorometholone ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fluticasone furoate
  • Siliq (brodalumab)
    +
    fluticasone furoate
    1 interaction

    Caution Advised

    brodalumab + fluticasone furoate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fluticasone propionate
  • Siliq (brodalumab)
    +
    fluticasone propionate
    1 interaction

    Caution Advised

    brodalumab + fluticasone propionate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fruquintinib
  • Siliq (brodalumab)
    +
    fruquintinib
    1 interaction

    Caution Advised

    brodalumab + fruquintinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • gemtuzumab ozogamicin
  • Siliq (brodalumab)
    +
    gemtuzumab ozogamicin
    1 interaction

    Caution Advised

    brodalumab + gemtuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • glofitamab
  • Siliq (brodalumab)
    +
    glofitamab
    1 interaction

    Caution Advised

    brodalumab + glofitamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • golimumab
  • Siliq (brodalumab)
    +
    golimumab
    1 interaction

    Caution Advised

    brodalumab + golimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • guselkumab
  • Siliq (brodalumab)
    +
    guselkumab
    1 interaction

    Caution Advised

    brodalumab + guselkumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • hydrocortisone
  • Siliq (brodalumab)
    +
    hydrocortisone
    1 interaction

    Caution Advised

    brodalumab + hydrocortisone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • hydrocortisone ophthalmic
  • Siliq (brodalumab)
    +
    hydrocortisone ophthalmic
    1 interaction

    Caution Advised

    brodalumab + hydrocortisone ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • hydroxyurea
  • Siliq (brodalumab)
    +
    hydroxyurea
    1 interaction

    Caution Advised

    brodalumab + hydroxyurea

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ibritumomab tiuxetan
  • Siliq (brodalumab)
    +
    ibritumomab tiuxetan
    1 interaction

    Caution Advised

    brodalumab + ibritumomab tiuxetan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ibrutinib
  • Siliq (brodalumab)
    +
    ibrutinib
    1 interaction

    Caution Advised

    brodalumab + ibrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • icotrokinra
  • Siliq (brodalumab)
    +
    icotrokinra
    1 interaction

    Caution Advised

    brodalumab + icotrokinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idarubicin
  • Siliq (brodalumab)
    +
    idarubicin
    1 interaction

    Caution Advised

    brodalumab + idarubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idecabtagene vicleucel
  • Siliq (brodalumab)
    +
    idecabtagene vicleucel
    1 interaction

    Caution Advised

    brodalumab + idecabtagene vicleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idelalisib
  • Siliq (brodalumab)
    +
    idelalisib
    1 interaction

    Caution Advised

    brodalumab + idelalisib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ifosfamide
  • Siliq (brodalumab)
    +
    ifosfamide
    1 interaction

    Caution Advised

    brodalumab + ifosfamide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inebilizumab
  • Siliq (brodalumab)
    +
    inebilizumab
    1 interaction

    Caution Advised

    brodalumab + inebilizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inotuzumab ozogamicin
  • Siliq (brodalumab)
    +
    inotuzumab ozogamicin
    1 interaction

    Caution Advised

    brodalumab + inotuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • iptacopan
  • Siliq (brodalumab)
    +
    iptacopan
    1 interaction

    Caution Advised

    brodalumab + iptacopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • irinotecan
  • Siliq (brodalumab)
    +
    irinotecan
    1 interaction

    Caution Advised

    brodalumab + irinotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • isatuximab
  • Siliq (brodalumab)
    +
    isatuximab
    1 interaction

    Caution Advised

    brodalumab + isatuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ixabepilone
  • Siliq (brodalumab)
    +
    ixabepilone
    1 interaction

    Caution Advised

    brodalumab + ixabepilone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ixekizumab
  • Siliq (brodalumab)
    +
    ixekizumab
    1 interaction

    Caution Advised

    brodalumab + ixekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lebrikizumab
  • Siliq (brodalumab)
    +
    lebrikizumab
    1 interaction

    Caution Advised

    brodalumab + lebrikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • leflunomide
  • Siliq (brodalumab)
    +
    leflunomide
    1 interaction

    Caution Advised

    brodalumab + leflunomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lenalidomide
  • Siliq (brodalumab)
    +
    lenalidomide
    1 interaction

    Caution Advised

    brodalumab + lenalidomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lifileucel
  • Siliq (brodalumab)
    +
    lifileucel
    1 interaction

    Caution Advised

    brodalumab + lifileucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • linvoseltamab
  • Siliq (brodalumab)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    brodalumab + linvoseltamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lisocabtagene maraleucel
  • Siliq (brodalumab)
    +
    lisocabtagene maraleucel
    1 interaction

    Caution Advised

    brodalumab + lisocabtagene maraleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lomustine
  • Siliq (brodalumab)
    +
    lomustine
    1 interaction

    Caution Advised

    brodalumab + lomustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • loncastuximab tesirine
  • Siliq (brodalumab)
    +
    loncastuximab tesirine
    1 interaction

    Caution Advised

    brodalumab + loncastuximab tesirine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • loteprednol ophthalmic
  • Siliq (brodalumab)
    +
    loteprednol ophthalmic
    1 interaction

    Caution Advised

    brodalumab + loteprednol ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • Siliq (brodalumab)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Caution Advised

    brodalumab + lymphocyte immune globulin, anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • melphalan
  • Siliq (brodalumab)
    +
    melphalan
    1 interaction

    Caution Advised

    brodalumab + melphalan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mercaptopurine
  • Siliq (brodalumab)
    +
    mercaptopurine
    1 interaction

    Caution Advised

    brodalumab + mercaptopurine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • methotrexate
  • Siliq (brodalumab)
    +
    methotrexate
    1 interaction

    Caution Advised

    brodalumab + methotrexate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • methylprednisolone
  • Siliq (brodalumab)
    +
    methylprednisolone
    1 interaction

    Caution Advised

    brodalumab + methylprednisolone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mirikizumab
  • Siliq (brodalumab)
    +
    mirikizumab
    1 interaction

    Caution Advised

    brodalumab + mirikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mitoxantrone
  • Siliq (brodalumab)
    +
    mitoxantrone
    1 interaction

    Caution Advised

    brodalumab + mitoxantrone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mogamulizumab
  • Siliq (brodalumab)
    +
    mogamulizumab
    1 interaction

    Caution Advised

    brodalumab + mogamulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • momelotinib
  • Siliq (brodalumab)
    +
    momelotinib
    1 interaction

    Caution Advised

    brodalumab + momelotinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mometasone implant
  • Siliq (brodalumab)
    +
    mometasone implant
    1 interaction

    Caution Advised

    brodalumab + mometasone implant

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mometasone inhaled
  • Siliq (brodalumab)
    +
    mometasone inhaled
    1 interaction

    Caution Advised

    brodalumab + mometasone inhaled

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mometasone nasal
  • Siliq (brodalumab)
    +
    mometasone nasal
    1 interaction

    Caution Advised

    brodalumab + mometasone nasal

    caution advised: combo may incr. risk of serious infection (additive effects)

  • monomethyl fumarate
  • Siliq (brodalumab)
    +
    monomethyl fumarate
    1 interaction

    Caution Advised

    brodalumab + monomethyl fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mosunetuzumab
  • Siliq (brodalumab)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    brodalumab + mosunetuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mycophenolate mofetil
  • Siliq (brodalumab)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    brodalumab + mycophenolate mofetil

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mycophenolic acid
  • Siliq (brodalumab)
    +
    mycophenolic acid
    1 interaction

    Caution Advised

    brodalumab + mycophenolic acid

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nadofaragene firadenovec intravesical
  • Siliq (brodalumab)
    +
    nadofaragene firadenovec intravesical
    1 interaction

    Caution Advised

    brodalumab + nadofaragene firadenovec intravesical

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • narsoplimab
  • Siliq (brodalumab)
    +
    narsoplimab
    1 interaction

    Caution Advised

    brodalumab + narsoplimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nelarabine
  • Siliq (brodalumab)
    +
    nelarabine
    1 interaction

    Caution Advised

    brodalumab + nelarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nipocalimab
  • Siliq (brodalumab)
    +
    nipocalimab
    1 interaction

    Caution Advised

    brodalumab + nipocalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • obecabtagene autoleucel
  • Siliq (brodalumab)
    +
    obecabtagene autoleucel
    1 interaction

    Caution Advised

    brodalumab + obecabtagene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • obinutuzumab
  • Siliq (brodalumab)
    +
    obinutuzumab
    1 interaction

    Caution Advised

    brodalumab + obinutuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ocrelizumab
  • Siliq (brodalumab)
    +
    ocrelizumab
    1 interaction

    Caution Advised

    brodalumab + ocrelizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ofatumumab
  • Siliq (brodalumab)
    +
    ofatumumab
    1 interaction

    Caution Advised

    brodalumab + ofatumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • oxaliplatin
  • Siliq (brodalumab)
    +
    oxaliplatin
    1 interaction

    Caution Advised

    brodalumab + oxaliplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ozanimod
  • Siliq (brodalumab)
    +
    ozanimod
    1 interaction

    Caution Advised

    brodalumab + ozanimod

    caution advised during and x3mo after ozanimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • paclitaxel
  • Siliq (brodalumab)
    +
    paclitaxel
    1 interaction

    Caution Advised

    brodalumab + paclitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pegcetacoplan
  • Siliq (brodalumab)
    +
    pegcetacoplan
    1 interaction

    Caution Advised

    brodalumab + pegcetacoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pentostatin
  • Siliq (brodalumab)
    +
    pentostatin
    1 interaction

    Caution Advised

    brodalumab + pentostatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pirtobrutinib
  • Siliq (brodalumab)
    +
    pirtobrutinib
    1 interaction

    Caution Advised

    brodalumab + pirtobrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • polatuzumab vedotin
  • Siliq (brodalumab)
    +
    polatuzumab vedotin
    1 interaction

    Caution Advised

    brodalumab + polatuzumab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pomalidomide
  • Siliq (brodalumab)
    +
    pomalidomide
    1 interaction

    Caution Advised

    brodalumab + pomalidomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ponatinib
  • Siliq (brodalumab)
    +
    ponatinib
    1 interaction

    Caution Advised

    brodalumab + ponatinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ponesimod
  • Siliq (brodalumab)
    +
    ponesimod
    1 interaction

    Caution Advised

    brodalumab + ponesimod

    caution advised during and x1-2wk after ponesimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • pozelimab
  • Siliq (brodalumab)
    +
    pozelimab
    1 interaction

    Caution Advised

    brodalumab + pozelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • prednisolone
  • Siliq (brodalumab)
    +
    prednisolone
    1 interaction

    Caution Advised

    brodalumab + prednisolone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • prednisolone ophthalmic
  • Siliq (brodalumab)
    +
    prednisolone ophthalmic
    1 interaction

    Caution Advised

    brodalumab + prednisolone ophthalmic

    caution advised: combo may incr. risk of serious infection (additive effects)

  • prednisone
  • Siliq (brodalumab)
    +
    prednisone
    1 interaction

    Caution Advised

    brodalumab + prednisone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • procarbazine
  • Siliq (brodalumab)
    +
    procarbazine
    1 interaction

    Caution Advised

    brodalumab + procarbazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • quizartinib
  • Siliq (brodalumab)
    +
    quizartinib
    1 interaction

    Caution Advised

    brodalumab + quizartinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ravulizumab
  • Siliq (brodalumab)
    +
    ravulizumab
    1 interaction

    Caution Advised

    brodalumab + ravulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • regorafenib
  • Siliq (brodalumab)
    +
    regorafenib
    1 interaction

    Caution Advised

    brodalumab + regorafenib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rilonacept
  • Siliq (brodalumab)
    +
    rilonacept
    1 interaction

    Caution Advised

    brodalumab + rilonacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rilzabrutinib
  • Siliq (brodalumab)
    +
    rilzabrutinib
    1 interaction

    Caution Advised

    brodalumab + rilzabrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • risankizumab
  • Siliq (brodalumab)
    +
    risankizumab
    1 interaction

    Caution Advised

    brodalumab + risankizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rituximab
  • Siliq (brodalumab)
    +
    rituximab
    1 interaction

    Caution Advised

    brodalumab + rituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • romidepsin
  • Siliq (brodalumab)
    +
    romidepsin
    1 interaction

    Caution Advised

    brodalumab + romidepsin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ropeginterferon alfa-2b
  • Siliq (brodalumab)
    +
    ropeginterferon alfa-2b
    1 interaction

    Caution Advised

    brodalumab + ropeginterferon alfa-2b

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rozanolixizumab
  • Siliq (brodalumab)
    +
    rozanolixizumab
    1 interaction

    Caution Advised

    brodalumab + rozanolixizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ruxolitinib
  • Siliq (brodalumab)
    +
    ruxolitinib
    1 interaction

    Caution Advised

    brodalumab + ruxolitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sarilumab
  • Siliq (brodalumab)
    +
    sarilumab
    1 interaction

    Caution Advised

    brodalumab + sarilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • satralizumab
  • Siliq (brodalumab)
    +
    satralizumab
    1 interaction

    Caution Advised

    brodalumab + satralizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • secukinumab
  • Siliq (brodalumab)
    +
    secukinumab
    1 interaction

    Caution Advised

    brodalumab + secukinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • selinexor
  • Siliq (brodalumab)
    +
    selinexor
    1 interaction

    Caution Advised

    brodalumab + selinexor

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sibeprenlimab
  • Siliq (brodalumab)
    +
    sibeprenlimab
    1 interaction

    Caution Advised

    brodalumab + sibeprenlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • siltuximab
  • Siliq (brodalumab)
    +
    siltuximab
    1 interaction

    Caution Advised

    brodalumab + siltuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • siponimod
  • Siliq (brodalumab)
    +
    siponimod
    1 interaction

    Caution Advised

    brodalumab + siponimod

    caution advised during and x3-4wk after siponimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • sirolimus
  • Siliq (brodalumab)
    +
    sirolimus
    1 interaction

    Caution Advised

    brodalumab + sirolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sirolimus albumin-bound
  • Siliq (brodalumab)
    +
    sirolimus albumin-bound
    1 interaction

    Caution Advised

    brodalumab + sirolimus albumin-bound

    caution advised: combo may incr. risk of serious infection (additive effects)

  • spesolimab
  • Siliq (brodalumab)
    +
    spesolimab
    1 interaction

    Caution Advised

    brodalumab + spesolimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sulfasalazine
  • Siliq (brodalumab)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    brodalumab + sulfasalazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sutimlimab
  • Siliq (brodalumab)
    +
    sutimlimab
    1 interaction

    Caution Advised

    brodalumab + sutimlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tacrolimus
  • Siliq (brodalumab)
    +
    tacrolimus
    1 interaction

    Caution Advised

    brodalumab + tacrolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tafasitamab
  • Siliq (brodalumab)
    +
    tafasitamab
    1 interaction

    Caution Advised

    brodalumab + tafasitamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • talquetamab
  • Siliq (brodalumab)
    +
    talquetamab
    1 interaction

    Caution Advised

    brodalumab + talquetamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tarlatamab
  • Siliq (brodalumab)
    +
    tarlatamab
    1 interaction

    Caution Advised

    brodalumab + tarlatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teclistamab
  • Siliq (brodalumab)
    +
    teclistamab
    1 interaction

    Caution Advised

    brodalumab + teclistamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • temozolomide
  • Siliq (brodalumab)
    +
    temozolomide
    1 interaction

    Caution Advised

    brodalumab + temozolomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • temsirolimus
  • Siliq (brodalumab)
    +
    temsirolimus
    1 interaction

    Caution Advised

    brodalumab + temsirolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teplizumab
  • Siliq (brodalumab)
    +
    teplizumab
    1 interaction

    Caution Advised

    brodalumab + teplizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teriflunomide
  • Siliq (brodalumab)
    +
    teriflunomide
    1 interaction

    Caution Advised

    brodalumab + teriflunomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • thioguanine
  • Siliq (brodalumab)
    +
    thioguanine
    1 interaction

    Caution Advised

    brodalumab + thioguanine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • thiotepa
  • Siliq (brodalumab)
    +
    thiotepa
    1 interaction

    Caution Advised

    brodalumab + thiotepa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tildrakizumab
  • Siliq (brodalumab)
    +
    tildrakizumab
    1 interaction

    Caution Advised

    brodalumab + tildrakizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tisagenlecleucel
  • Siliq (brodalumab)
    +
    tisagenlecleucel
    1 interaction

    Caution Advised

    brodalumab + tisagenlecleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tocilizumab
  • Siliq (brodalumab)
    +
    tocilizumab
    1 interaction

    Caution Advised

    brodalumab + tocilizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tofacitinib
  • Siliq (brodalumab)
    +
    tofacitinib
    1 interaction

    Caution Advised

    brodalumab + tofacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • topotecan
  • Siliq (brodalumab)
    +
    topotecan
    1 interaction

    Caution Advised

    brodalumab + topotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • trabectedin
  • Siliq (brodalumab)
    +
    trabectedin
    1 interaction

    Caution Advised

    brodalumab + trabectedin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tralokinumab
  • Siliq (brodalumab)
    +
    tralokinumab
    1 interaction

    Caution Advised

    brodalumab + tralokinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • triamcinolone
  • Siliq (brodalumab)
    +
    triamcinolone
    1 interaction

    Caution Advised

    brodalumab + triamcinolone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tuberculin purified protein derivative
  • Siliq (brodalumab)
    +
    tuberculin purified protein derivative
    1 interaction

    Caution Advised

    brodalumab + tuberculin purified protein derivative

    caution advised during and x5-6wk after brodalumab tx: combo may interfere with test results (antagonistic effects)

  • ublituximab
  • Siliq (brodalumab)
    +
    ublituximab
    1 interaction

    Caution Advised

    brodalumab + ublituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ustekinumab
  • Siliq (brodalumab)
    +
    ustekinumab
    1 interaction

    Caution Advised

    brodalumab + ustekinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vamorolone
  • Siliq (brodalumab)
    +
    vamorolone
    1 interaction

    Caution Advised

    brodalumab + vamorolone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vedolizumab
  • Siliq (brodalumab)
    +
    vedolizumab
    1 interaction

    Caution Advised

    brodalumab + vedolizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • venetoclax
  • Siliq (brodalumab)
    +
    venetoclax
    1 interaction

    Caution Advised

    brodalumab + venetoclax

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vilobelimab
  • Siliq (brodalumab)
    +
    vilobelimab
    1 interaction

    Caution Advised

    brodalumab + vilobelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinblastine
  • Siliq (brodalumab)
    +
    vinblastine
    1 interaction

    Caution Advised

    brodalumab + vinblastine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vincristine
  • Siliq (brodalumab)
    +
    vincristine
    1 interaction

    Caution Advised

    brodalumab + vincristine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinorelbine
  • Siliq (brodalumab)
    +
    vinorelbine
    1 interaction

    Caution Advised

    brodalumab + vinorelbine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • voclosporin
  • Siliq (brodalumab)
    +
    voclosporin
    1 interaction

    Caution Advised

    brodalumab + voclosporin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • zanubrutinib
  • Siliq (brodalumab)
    +
    zanubrutinib
    1 interaction

    Caution Advised

    brodalumab + zanubrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • zilucoplan
  • Siliq (brodalumab)
    +
    zilucoplan
    1 interaction

    Caution Advised

    brodalumab + zilucoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@20c82387
  • hypersensitivity reaction
  • anaphylaxis
  • shock
  • eczematous eruption, severe
  • suicidality
  • infection, serious
  • Crohn disease exacerbation
  • neutropenia

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@5bf515c9
  • infection
  • arthralgia
  • headache
  • fatigue
  • diarrhea
  • oropharyngeal pain

Safety/Monitoring .

Monitoring Parameters
TB test at baseline, then active TB signs/symptoms during and after tx D/C

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no human data available; no known risk of embryo-fetal toxicity based on animal data at up to 26x MRHD

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@28ec358e

Metabolism: for brodalumab: unknown; CYP450: unknown

Excretion: for brodalumab: unknown; Half-life: unknown

Subclass: Interleukin-17 (IL-17) Antagonists ; Psoriasis, Systemic Agents

Mechanism of Action
for brodalumab: selectively binds to IL-17RA and inhibits IL-17 cytokine-induced responses including release of pro-inflammatory cytokines and chemokines (monoclonal antibody)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Bausch Health Companies Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@64b111a1

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

subcutaneous solution:

  • 210 mg/1.5 mL (1 carton, 2 syringes): $2,684.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information